1419169-87-1

Basic information

• Product Name: 2-(2-{5-[3-(carboxymethyl)-5-[4-(methylsulfamoyl)phenyl]thiophen-2-yl]thiophen-2-yl}-5-[4-(methylsulfamoyl)phenyl]thiophen-3-yl)acetic acid
• Synonyms: 2-(2-{5-[3-(carboxymethyl)-5-[4-(methylsulfamoyl)phenyl]thiophen-2-yl]thiophen-2-yl}-5-[4-(methylsulfamoyl)phenyl]thiophen-3-yl)acetic acid
• CAS NO: 1419169-87-1
• Molecular Weight: 702.875
• Mol File: 1419169-87-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(2-{5-[3-(carboxymethyl)-5-[4-(methylsulfamoyl)phenyl]thiophen-2-yl]thiophen-2-yl}-5-[4-(methylsulfamoyl)phenyl]thiophen-3-yl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-{5-[3-(carboxymethyl)-5-[4-(methylsulfamoyl)phenyl]thiophen-2-yl]thiophen-2-yl}-5-[4-(methylsulfamoyl)phenyl]thiophen-3-yl)acetic acid(1419169-87-1)
• EPA Substance Registry System: 2-(2-{5-[3-(carboxymethyl)-5-[4-(methylsulfamoyl)phenyl]thiophen-2-yl]thiophen-2-yl}-5-[4-(methylsulfamoyl)phenyl]thiophen-3-yl)acetic acid(1419169-87-1)

Safety Data

• Hazardous Substances Data: 1419169-87-1(Hazardous Substances Data)

Upstream product

• 959627-56-6 methyl 2-(2-{5-[3-(2-methoxy-2-oxoethyl)thiophen-2-yl]thiophen-2-yl}thiophen-3-yl)acetate 
• 683251-61-8 methyl 2-(2-bromothiophene-3-yl)acetate 
• 6964-21-2 thiophen-3-yl-acetic acid 
• 58414-52-1 thiophen-3-yl-acetic acid methyl ester 
• 1419171-64-4 methyl 2-(5-bromo-2-{5-[5-bromo-3-(2-methoxy-2-oxoethyl)thiophen-2-yl]thiophen-2-yl}thiophen-3-yl)acetate 
• 1419171-71-3 2-(5-bromo-2-{5-[5-bromo-3-(carboxymethyl)thiophen-2-yl]thiophen-2-yl}thiophen-3-yl)acetic acid 
• 226396-31-2 (4-[N-methylsulfamoyl]phenyl)boronic acid 

Relevant articles and documents

NOVEL COMPOUNDS AND THEIR USE IN THERAPY

The present invention relates to novel chemical compounds formula (I) (C)n-B-(A)m-B-(C)n (I) wherein m is 0 or 1, and n is independently 0, 1, 2 or 3, A, each B and each C are independently selected from phenylene and five-and six-membered heteroaromatic rings, and for a terminal ring B or C also from bicyclic heteroaromatic fused rings having seven to ten ring members, wherein the bond between at least two of the rings A to C may be replaced by a carbonyl group (-CO-), wherein at least two of the rings A to C are substituted with one or two groups R, and wherein each ring A to C further optionally is substituted with one or two groups R1. The compounds are useful in therapy, especially therapy of a mammal suffering from a disease involving misfolded or aggregated forms of proteins.